Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategies.

[1]  Lin Guo.  Women's health in rural China , 2012 .

[2]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[3]  Y. Qiao,et al.  Cost‐effectiveness analysis of cervical cancer prevention based on a rapid human papillomavirus screening test in a high‐risk region of China , 2010, International journal of cancer.

[4]  S. Franceschi,et al.  Erratum to “Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia” [Vaccine 26 (Suppl. 12) (2008) M53–M59] , 2010 .

[5]  Ranjit Thorat,et al.  HPV screening for cervical cancer in rural India. , 2009, The New England journal of medicine.

[6]  N. Xia,et al.  [Production of human papillomavirus type 16 virus-like particles and its immunogenicity]. , 2009, Bing du xue bao = Chinese journal of virology.

[7]  N. Xia,et al.  [Expression, purification and immunogenicity analysis of HPV type 18 virus-like particles from Escherichia coli]. , 2009, Sheng wu gong cheng xue bao = Chinese journal of biotechnology.

[8]  Y. Qiao,et al.  Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China. , 2009, Vaccine.

[9]  J. Lew,et al.  The predicted impact of vaccination on human papillomavirus infections in Australia , 2008, International journal of cancer.

[10]  Feng Chen,et al.  A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. , 2008, The Lancet. Oncology.

[11]  S. Franceschi,et al.  Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia. , 2008, Vaccine.

[12]  S. Goldie,et al.  Mathematical models of cervical cancer prevention in the Asia Pacific region. , 2008, Vaccine.

[13]  S. Goldie,et al.  Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy. , 2008, Vaccine.

[14]  F. X. Bosch,et al.  Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India , 2008, British Journal of Cancer.

[15]  D. Ma,et al.  Production and verification of human papillomavirus type 18 vaccine in vitro. , 2008, Oncology reports.

[16]  Li Zhao,et al.  Human papillomavirus type 16 L1E7 chimeric capsomeres have prophylactic and therapeutic efficacy against papillomavirus in mice , 2008, Molecular Cancer Therapeutics.

[17]  S. Goldie,et al.  Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications , 2008, Reproductive health matters.

[18]  S. Franceschi,et al.  Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study , 2006, British Journal of Cancer.

[19]  M. Lehtinen,et al.  Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses , 2006, PLoS medicine.

[20]  A. Rothberg.  Making Choices in Health: WHO Guide to Cost Effectiveness Analysis , 2008 .

[21]  V Beral,et al.  The predicted effect of changes in cervical screening practice in the UK: results from a modelling study , 2004, British Journal of Cancer.

[22]  Gui-ying Wu,et al.  [Study on the cost-effectiveness, benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai]. , 2004, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[23]  F. Bray,et al.  Estimation and projection of the national profile of cancer mortality in China: 1991–2005 , 2004, British Journal of Cancer.

[24]  Rob Baltussen,et al.  Making Choices in Health: WHO Guide to Cost Effectiveness Analysis , 2003 .

[25]  Y. Qiao,et al.  Erratum: "Shanxi Province Cervical Cancer Screening Study: A Cross-Sectional Comparative Trial of Multiple Techniques to Detect Cervical Neoplasia," (Gynecologic Oncology (2001) 83:2(439-444) , 2002 .

[26]  J. Sachs.  Macroeconomics and health: investing in health for economic development , 2002 .

[27]  Y. Qiao,et al.  Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. , 2001, Gynecologic oncology.

[28]  W. Cao,et al.  [Cost-effectiveness analysis of hepatitis B vaccination in People's Liberation Army]. , 2001, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[29]  Z. G. Liu,et al.  [Cost-benefit analysis on immunization of newborns with hepatitis B vaccine in Jinan City]. , 1995, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[30]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.